MENU
+Compare
GLMD
Stock ticker: NASDAQ
AS OF
Jun 5 closing price
Price
$1.49
Change
-$0.02 (-1.32%)
Capitalization
3.36M

GLMD Galmed Pharmaceuticals Ltd Forecast, Technical & Fundamental Analysis

Galmed Pharmaceuticals Ltd is a biopharmaceutical company... Show more

GLMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for GLMD with price predictions
Jun 05, 2025

GLMD in upward trend: price rose above 50-day moving average on June 02, 2025

GLMD moved above its 50-day moving average on June 02, 2025 date and that indicates a change from a downward trend to an upward trend. In of 37 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on May 21, 2025. You may want to consider a long position or call options on GLMD as a result. In of 97 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The 10-day moving average for GLMD crossed bullishly above the 50-day moving average on June 03, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GLMD advanced for three days, in of 213 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GLMD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

GLMD broke above its upper Bollinger Band on May 27, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.199) is normal, around the industry mean (16.332). P/E Ratio (0.019) is within average values for comparable stocks, (59.787). GLMD's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.227). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (263.647).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. GLMD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GLMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
GLMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

GLMD is expected to report earnings to rise 18.52% to -31 cents per share on March 14

Galmed Pharmaceuticals Ltd GLMD Stock Earnings Reports
Q4'23
Est.
$-0.32
Q3'23
Beat
by $0.03
Q2'23
Est.
$-0.34
Q1'23
Beat
by $0.41
Q4'22
Missed
by $1.36
The last earnings report on November 06 showed earnings per share of -27 cents, beating the estimate of -30 cents. With 203.61K shares outstanding, the current market capitalization sits at 3.36M.
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
16 Tiomkin Street
Phone
+972 36938448
Employees
10
Web
https://www.galmedpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SCNI3.070.55
+21.83%
Scinai Immunotherapeutics Ltd.
BATRK40.26-0.12
-0.30%
Atlanta Braves Holdings
ZG68.93-0.22
-0.32%
Zillow Group
DDD1.67-0.02
-1.18%
3D Systems Corp
PRPH0.36-0.03
-6.99%
ProPhase Labs

GLMD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, GLMD has been closely correlated with XBIO. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if GLMD jumps, then XBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLMD
1D Price
Change %
GLMD100%
-1.32%
XBIO - GLMD
88%
Closely correlated
+0.95%
IOBT - GLMD
34%
Loosely correlated
+3.10%
JSPR - GLMD
31%
Poorly correlated
-5.08%
CDTX - GLMD
28%
Poorly correlated
N/A
CRVS - GLMD
28%
Poorly correlated
+4.13%
More